Biotech news
Americas
The Pharmaceutical Research and Manufacturers of America (PhRMA) group discussed trade agreements and removing outdated regulations with US President Donald Trump yesterday. 2 February 2017
Americas
US biotech company Twist Bioscience and its CEO, Emily LeProust, have countered allegations made against the company last year with a lawsuit. 1 February 2017
Africa
Global intellectual property strategy will be the chief area of focus for IP counsel in the life sciences arena in 2017. 26 January 2017
Americas
The US Court of Appeals for the Federal Circuit has vacated a district court’s grant of summary judgment of non-infringement and remanded a case involving China-based Zhejiang Medicine, Japanese company Keneka and ZMC-USA. 25 January 2017
Americas
The Federal Trade Commission and the Department of Justice have issued an update to the Antitrust Guidelines for Licensing of Intellectual Property, modernising the 1995 guidelines. 18 January 2017
Biotech
UK-based Horizon Discovery has broadened its gene editing capabilities through the amendment of a pre-existing licence with ERS Genomics to include the full commercial rights for the use of CRISPR. 17 January 2017
Americas
The US Supreme Court has agreed to hear the biosimilars dispute between Amgen and Sandoz. 16 January 2017
Americas
Pharmaceutical research company Phigenix lost an appeal at the US Court of Appeals for the Federal Circuit yesterday, after the court found that the company lacked standing in a patent case against ImmunoGen. 10 January 2017
Biotech
Several changes have been made to Italy’s regulatory landscape for biosimilars, as Luca Tosoni of Covington & Burling reports. 10 January 2017
Americas
Sanofi and Regeneron Pharmaceuticals have revealed plans to appeal against an injunction granted to Amgen, which prevents the companies from selling cholesterol-lowering medicine Praluent. 9 January 2017